Heat Biologics raised $5 million in its latest round of equity funding. The firm, based in Chapel Hill, N.C., will use the money to support clinical trials of its lung cancer and bladder cancer drugs.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan